Description
The New York Harbor Healthcare System is issuing a notice of intent to award a sole source contract to Optum Infusion 308, LLC, for compounded chemotherapy drugs preparation and delivery. The contract requires the delivery of "ready to administer" drugs on a patient-specific basis, with a 15-point check system capabilities done by pharmacists on each prescription, and a one-day turnaround time on all prescriptions. The contract is for a period of one year, from August 24, 2026, to September 30, 2027. Interested parties may submit expressions of interest, including pricing data and technical data, to determine if a comparable source is available.
• The contract requires compliance with VHA Directive 1108.12, USP 797 standards, and FDA requirements.
• The contractor must have the capability to deliver "ready to administer" drugs on a patient-specific basis.
• The contractor must have a 15-point check system capabilities done by pharmacists on each prescription.
• The contractor must have a one-day turnaround time on all prescriptions.